Thoracic Eosinophilic Granuloma Imaging
- Author: Scott C Williams, MD; Chief Editor: Barry H Gross, MD more...
Overview
Langerhans cell histiocytosis (LCH) describes a group of syndromes that share the common pathologic feature of infiltration of involved tissues by Langerhans cells. Typically, the skeletal system is involved, with a characteristic lytic bone lesion form that occurs in young children or a more acute disseminated form that occurs in infants. Pulmonary involvement is not unusual in systemic forms of LCH, but symptoms are rarely a prominent feature. CT scans of eosinophilic granuloma are depicted in the images below.
Chest CT in a patient with pulmonary eosinophilic granuloma demonstrates scattered cavitary and noncavitary nodules.
High-resolution chest CT scan in a patient with pulmonary eosinophilic granuloma shows the typical combination of nodules, cavitated nodules, and thick- and thin-walled cysts. Image courtesy of European Respiratory Society Journals LTD.
High-resolution chest CT scan in a patient with advanced pulmonary eosinophilic granuloma shows numerous pulmonary cysts of various sizes, which are confluent in some places. Image courtesy of European Respiratory Society Journals LTD. Localized pulmonary LCH (also termed pulmonary eosinophilic granuloma) is a rare pulmonary disease that occurs predominantly in young adults. The precise incidence and prevalence of pulmonary LCH are unknown, although studies of lung biopsy specimens from patients with interstitial lung disease identified pulmonary LCH in only 5%.
A confident diagnosis of pulmonary LCH often can be made based on the patient's age, smoking history, and characteristic high-resolution computed tomography (HRCT) scan findings, especially if patients are followed without treatment.
Definitive diagnosis, if necessary, can be made by identification of Langerhans cell granulomas in lung biopsy samples acquired by video-assisted thoracoscopy. Biopsy sites are selected on the basis of HRCT scan findings.[1] Transbronchial biopsy has a low diagnostic yield (10-40%) because of the patchy nature of the disease and the small amounts of tissue obtained.
Treatment consists of smoking cessation, which stabilizes symptoms in most patients. Corticosteroids are used in progressive or systemic disease. Cytotoxic agents (eg, cyclophosphamide) can be employed for patients who do not respond to smoking cessation and steroids. No treatment has been confirmed to be useful, and no double-blind therapeutic trials have been reported. Lung transplantation also has been performed for treatment of LCH.
Preferred examination
In patients with suggested eosinophilic granuloma, obtain a chest radiograph and a chest HRCT scan.[1, 2]
Radiography
Chest radiographs are normal in fewer than 10% of patients. Usually, diffuse reticulonodularity (3- to 10-mm nodules that may cavitate) is observed in a symmetrical pattern, predominantly in the upper and middle lobes (bases tend to be spared).[3]
Lung volumes are generally preserved, or even increased, in contrast to most other pulmonary infiltrative diseases.[1] Associated pneumothorax is found in 15-25% of patients, and pleural effusion is rare.
In the late stage, diffuse cysts may be found that spare only the costophrenic angles.
Computed Tomography
On chest HRCT scans, the distribution of the disease is similar to that seen on chest radiography, with an upper lobe predominance (see the images below). Findings include the following:
- Centrilobular opacities
- Small nodules (1-5 mm, may be up to 1.5 cm)
- Cystic cavitation of small nodules; this is not readily visible on plain radiographs[1]
- Cysts (initially thick walled, typically progressing to thin walled over time)
Chest CT in a patient with pulmonary eosinophilic granuloma demonstrates scattered cavitary and noncavitary nodules.
High-resolution chest CT scan in a patient with pulmonary eosinophilic granuloma shows the typical combination of nodules, cavitated nodules, and thick- and thin-walled cysts. Image courtesy of European Respiratory Society Journals LTD.
High-resolution chest CT scan in a patient with advanced pulmonary eosinophilic granuloma shows numerous pulmonary cysts of various sizes, which are confluent in some places. Image courtesy of European Respiratory Society Journals LTD.
Some authors believe that nodules do not cavitate and cysts represent a paracicatricial emphysematous change adjacent to nodules. Cysts usually are smaller than 10 mm, although cysts larger than 10 mm are found in more than 50% of patients. Cyst walls usually are thin (less than 1 mm) but can vary, and the cysts are not necessarily round; they may be bilobed or branching. The intervening lung parenchyma appears normal. The extent of cystic involvement seen on HRCT scans has been correlated with the degree of lung function impairment.[4]
In the early stages, only nodules may be seen. In the late stages, diffuse cysts may be seen, with no nodules evident (approximately 20% of patients). Late-stage disease may be indistinguishable from lymphangiomyomatosis; however, sparing of the costophrenic angles suggests the diagnosis of eosinophilic granuloma. Mediastinal adenopathy has been described in some series but usually is uncommon. Other authors report mediastinal adenopathy in as many as 30% of patients.[5, 6]
Degree of confidence
A diagnosis of pulmonary eosinophilic granuloma can be established with a high degree of confidence when small nodules and cysts are seen in a young adult patient with a history of smoking.[7, 8]
Nuclear Imaging
Gallium-67 scans usually are negative.
Tazi A. Adult pulmonary Langerhans' cell histiocytosis. Eur Respir J. Jun 2006;27(6):1272-85. [Medline]. [Full Text].
Vrielynck S, Mamou-Mani T, Emond S, Scheinmann P, Brunelle F, de Blic J. Diagnostic value of high-resolution CT in the evaluation of chronic infiltrative lung disease in children. AJR Am J Roentgenol. Sep 2008;191(3):914-20. [Medline].
Sundar KM, Gosselin MV, Chung HL, Cahill BC. Pulmonary Langerhans cell histiocytosis: emerging concepts in pathobiology, radiology, and clinical evolution of disease. Chest. May 2003;123(5):1673-83. [Medline]. [Full Text].
Canuet M, Kessler R, Jeung MY, Métivier AC, Chaouat A, Weitzenblum E. Correlation between high-resolution computed tomography findings and lung function in pulmonary Langerhans cell histiocytosis. Respiration. 2007;74(6):640-6. [Medline].
Brauner MW, Grenier P, Tijani K. Pulmonary Langerhans cell histiocytosis: evolution of lesions on CT scans. Radiology. Aug 1997;204(2):497-502. [Medline].
Colby TV, Swensen SJ. Anatomic distribution and histopathologic patterns in diffuse lung disease: correlation with HRCT [published erratum appears in J Thorac Imaging 1996 Spring;11(2):163]. J Thorac Imaging. Winter 1996;11(1):1-26. [Medline].
Bonelli FS, Hartman TE, Swensen SJ. Accuracy of high-resolution CT in diagnosing lung diseases. AJR Am J Roentgenol. Jun 1998;170(6):1507-12. [Medline].
Hartman TE, Tazelaar HD, Swensen SJ. Cigarette smoking: CT and pathologic findings of associated pulmonary diseases. Radiographics. Mar-Apr 1997;17(2):377-90. [Medline].

